KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Liabilities and Shareholders Equity (2020 - 2025)

Organon (OGN) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $12.9 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 1.79% year-over-year to $12.9 billion; the TTM value through Dec 2025 reached $53.1 billion, up 6.37%, while the annual FY2025 figure was $12.9 billion, 1.79% down from the prior year.
  • Liabilities and Shareholders Equity reached $12.9 billion in Q4 2025 per OGN's latest filing, down from $13.6 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $13.6 billion in Q3 2025 and bottomed at $9.6 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $11.6 billion, with a median of $11.2 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 7.92% in 2022, then increased 15.8% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $10.7 billion in 2021, then increased by 2.57% to $11.0 billion in 2022, then rose by 10.07% to $12.1 billion in 2023, then grew by 8.65% to $13.1 billion in 2024, then dropped by 1.79% to $12.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $12.9 billion in Q4 2025, $13.6 billion in Q3 2025, and $13.5 billion in Q2 2025.